Activated Leukocyte Cell Adhesion Molecule/CD166, a Marker of Tumor Progression in Primary Malignant Melanoma of the Skin
Top Cited Papers
Open Access
- 1 March 2000
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 156 (3) , 769-774
- https://doi.org/10.1016/s0002-9440(10)64943-7
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Mechanisms of metastasisCritical Reviews in Oncology/Hematology, 1997
- CD6—ligand interactions: a paradigm for SRCR domain function?Immunology Today, 1997
- Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.The Journal of Experimental Medicine, 1995
- Identification and characterization of a 100-kD ligand for CD6 on human thymic epithelial cells.The Journal of Experimental Medicine, 1995
- Molecular and cellular basis of cancer invasion and metastasis: Implications for treatmentBritish Journal of Surgery, 1994
- Lessons from Tumor Progression: The Invasive Radial Growth Phase of Melanoma Is Common, Incapable of Metastasis, and IndolentJournal of Investigative Dermatology, 1993
- Lessons from Tumor Progression: The Invasive Radial Growth Phase of Melanoma Is Common, Incapable of Metastasis, and Indolent.Journal of Investigative Dermatology, 1993
- Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sitesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1988
- The pathogenesis of cancer metastasisNature, 1980
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970